10x Genomics Unveils Plan For Mega-Scale Single Cell Analysis At One Cent Per Cell, Offering Cost-Effective Solutions For High-Throughput CRISPR Screens And Cell Atlassing Projects
Portfolio Pulse from Benzinga Newsdesk
10x Genomics has announced a plan to offer mega-scale single cell analysis at a cost of one cent per cell. This initiative aims to provide cost-effective solutions for high-throughput CRISPR screens and cell atlasing projects.
October 01, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
10x Genomics has introduced a plan to offer single cell analysis at one cent per cell, potentially increasing its market share in CRISPR screens and cell atlasing projects.
The announcement of a cost-effective solution for single cell analysis positions 10x Genomics as a competitive player in the genomics market. This could lead to increased adoption of their technology, positively impacting their stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100